Aino Health AB (publ): Aino Health strengthens management team
/
Date04 Jan 2017
PRESS RELEASE January 04, 2017 Aino Health strengthens management team NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO NEWS DISTRIBUTORS IN THE UNITED STATES,... Read More →
Aino Health AB (publ): Aino Health stärker ledningsgruppen
/
Date04 Jan 2017
PRESSINFORMATION 04 januari 2017 Leif Fågelstedt tillträder rollen som Chief Marketing Officer och blir därmed en del av Aino Healths ledningsgrupp. Leif Fågelstedt har lång... Read More →
Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
/
Date03 Jan 2017
DUBLIN – Jan. 3, 2017 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 35th Annual J.P.... Read More →
Sugarlands Distilling Company Nominates Fifty Nonprofits for MoonShare Grants
/
Date03 Jan 2017
first_moonsharesslide GATLINBURG, Tenn., Jan. 3, 2017 (GLOBE NEWSWIRE) — Sugarlands Distilling Company, distillers of award-winning spirits in East Tennessee, recently nominated 50 nonprofit organizations for... Read More →
Adamas Pharmaceuticals Completes Phase 1 Clinical Trial of ADS-4101 for Treatment of Partial Onset Seizures in Patients with Epilepsy
/
Date03 Jan 2017
EMERYVILLE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the completion of a Phase 1 clinical trial of ADS-4101, an... Read More →
Agile Therapeutics Announces Positive Top-line Phase 3 Results
/
Date03 Jan 2017
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of 2017 Company to Host Conference... Read More →
AB Science announces that new preclinical data demonstrate that masitinib has an unexpected protective effect on muscles and nerves in amyotrophic lateral sclerosis
/
Date03 Jan 2017
CPEng.pdf Paris, January 3 2017, 6.45pm New preclinical data demonstrate that masitinib has an unexpected protective effect on muscles and nerves in amyotrophic lateral sclerosis (ALS)... Read More →
AB Science annonce que de nouvelles données précliniques démontrent que le masitinib a un effet protecteur inattendu sur les muscles et les nerfs dans la sclérose latérale amyotrophique
/
Date03 Jan 2017
CPFR.pdf Paris, 3 janvier 2017, 18h45 De nouvelles données précliniques démontrent que le masitinib a un effet protecteur inattendu sur les muscles et les nerfs dans... Read More →
Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2017
/
Date03 Jan 2017
ROCKVILLE, Md., Jan. 03, 2017 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment... Read More →
EndoLogic Acquires Renzapride from Alizyme, plc
/
Date03 Jan 2017
CLIFTON, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) — EndoLogic, a company focused on the development and commercialization of products that treat gastrointestinal diseases, has acquired... Read More →